Statins and the perioperative period

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 3, 2007, Pages 231-236

  Bronheim, David ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Morbidity; Mortality; Perioperative period; Statins; Surgery

Indexed keywords

ATORVASTATIN; STATIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HIGH RISK PATIENT; HUMAN; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PUBLICATION; RETROSPECTIVE STUDY; RISK REDUCTION;

CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERIOPERATIVE CARE; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 34548137002     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253207306100     Document Type: Article

References (34)

1. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 1006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on focused update on perioperative beta blocker therapy. Circulation. 2006 ; 113: 2662-2674.
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106: 3143-3421.
3. Fletcher GF, Bufalino V., Costa F., et al. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am J Cardiol. 2007 ; 99: S1 - S35.
4. Thavendiranathan P., Bagani A., Broskhart MA Primary prevention of cardiovascular diseases with statin therapy. Arch Intern Med. 2006 ; 166: 2307-2313.
5. Ray KK, Cannon CP, Ganz P. Beyond lipid lowering, what have we learned about the benefits of statins from the acute coronary syndromes trial. Am J Cardiol. 2006 ; 98 (suppl): 18P - 25P.
6. Stanco C., Ance S. Statins mechanism of action and effect. J Am Mol Med. 2001 ; 5: 378-387.
7. Pan W., Pintar T., Anton J., Lee VV, Vaughn WK, Collard CD Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004 ; 110: 1145-1149.
8. Clark LL, Ikonomidis JS, Crawford FA, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006 ; 131: 679-685.
9. Collard CD, Body SC, Sherman SK, et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2006 ; 132: 392-400.
10. Ali IS, Buth KJ Preoperative statin use and outcome following cardiac surgery. Int J Cardiol. 2005 ; 103: 12-18.
11. Aboyens V., Labrousse L., Guilloux J., et al. Predictive factors of stroke in patients undergoing coronary artery bypass grafting: statins are protective. Eur J Cardiothorac Surg. 2006 ; 30: 300-304.
12. Patti G., Chello M., Candana D., et al. Randomized trial of atorvastatin Qfo, reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 study. Circulation. 2006 ; 114: 1455-1461.
13. Hindler K., Shaw A., Samuels J., et al. Improved postoperative outcome dissociation with preoperative statin therapy. Anesthesiology. 2006 ; 105: 1260-1272.
14. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004 ; 39: 967-975.
15. Poldermans D., Bax JJ, Kertal MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003 ; 107: 1848-1851.
16. Kertai MD, Boersma E., Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2004 ; 28: 343-352.
17. Kertai MD, Boersma E., Westerhout CM, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med. 2004 ; 116: 96-103.
18. McGirt MJ, Perler BA, Brook BS,, et al. 3-hydroxy-3-mehnylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005 ; 42: 829-836.
19. O'Neil-Callahan K., Katsimaglis G., Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the statins for risk reduction in surgery (StaRRS) study. J Am Coll Cardiol. 2005 ; 45: 336-342.
20. Kennedy J., Quan H., Buchan AM, Ghali WA, Feasby TE Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005 ; 36: 2072.
21. Parker WR, Leeper NJ, Kitpatrick JN, et al. The effect of preoperative statins on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol. 2005 ; 104: 264-268.
22. Abbruzzese TA, Havens J., Belkin M., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004 ; 39: 1178-1185.
23. Hindler K., Shaw A., Samuels J., et al. Improved postoperative outcome dissociation with preoperative statin therapy. Anesthesiology. 2006 ; 105: 1260-1272.
24. Noordzij PG, Poldermans D., Schouten O. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac nonvascular surgery. Coronary Artery Dis. 2007 ; 18: 67-72.
25. Lee TH, Marcontonio ER, Marjiore CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery. Circulation. 1999 ; 100: 1043-1049.
26. Lindenauer PK, Pekow P., Wang K., Gutierrez B., Benjamin EM Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004 ; 291: 2092-2099.
27. Schouten O., Polermans D., Visser L., et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J. 2004 ; 148: 1047-1052.
28. Ray KK, Cannon CP, Ganz P. Beyond lipid lowering: what have we learned about the benefits of statin from the acute coronary syndrome trials ? Am J Cardiol. 2006 ; 40: 567-572.
29. American College of Cardiology/American Heart Association/ National Heart Lung Blood Institute. Clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002 ; 40: 567-572.
30. Forestier F., Breton Y., Bonnet E., Janvier G. Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients with statins. Anesthesiology. 2002 ; 97: 1019-1021.
31. Schouten O., Kertai MD, Bax JJ, et al. Safety of perioperative statin use in high-risk patients undergoing vascular surgery. Am J Cardiol. 2005 ; 95: 658-660.
32. LeManach Y., Godet G., Coriat P. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007 ; 106: 1326-1333.
33. Heescher C., Hemm CW, Loufs U., et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002 ; 105: 1446-1452.
34. Biccard BM, Seer JW, Foex P. Statin therapy: a potentially useful perioperative intervention in patients with cardiovascular disease. Anaesthesia. 2005 ; 60: 1105-1114.